DE60100750D1 - NEUE KRISTALLINE FORM VON N-[4-[2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO[2,3-d]-PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMINSÄURE UND VERFAHREN FÜR IHRE HERSTELLUNG - Google Patents
NEUE KRISTALLINE FORM VON N-[4-[2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO[2,3-d]-PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMINSÄURE UND VERFAHREN FÜR IHRE HERSTELLUNGInfo
- Publication number
- DE60100750D1 DE60100750D1 DE60100750T DE60100750T DE60100750D1 DE 60100750 D1 DE60100750 D1 DE 60100750D1 DE 60100750 T DE60100750 T DE 60100750T DE 60100750 T DE60100750 T DE 60100750T DE 60100750 D1 DE60100750 D1 DE 60100750D1
- Authority
- DE
- Germany
- Prior art keywords
- pyrrolo
- pyrimidin
- dihydro
- benzoyl
- oxo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18496400P | 2000-02-25 | 2000-02-25 | |
US184964P | 2000-02-25 | ||
PCT/US2001/001229 WO2001062760A2 (en) | 2000-02-25 | 2001-02-12 | A NOVEL CRYSTALLINE FORM OF N-[4-[2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO[2,3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60100750D1 true DE60100750D1 (de) | 2003-10-16 |
DE60100750T2 DE60100750T2 (de) | 2004-07-29 |
Family
ID=22679017
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60100750T Expired - Lifetime DE60100750T2 (de) | 2000-02-25 | 2001-02-12 | NEUE KRISTALLINE FORM VON N-[4-[2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO[2,3-d]-PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMINSÄURE UND VERFAHREN FÜR IHRE HERSTELLUNG |
Country Status (36)
Country | Link |
---|---|
US (1) | US7138521B2 (de) |
EP (1) | EP1259513B1 (de) |
JP (1) | JP4846158B2 (de) |
KR (1) | KR100744917B1 (de) |
CN (1) | CN1183135C (de) |
AR (1) | AR029471A1 (de) |
AT (1) | ATE249462T1 (de) |
AU (1) | AU777047B2 (de) |
BR (1) | BR0108604A (de) |
CA (1) | CA2400155C (de) |
CO (1) | CO5261585A1 (de) |
CZ (1) | CZ303772B6 (de) |
DE (1) | DE60100750T2 (de) |
DK (1) | DK1259513T3 (de) |
DZ (1) | DZ3283A1 (de) |
EA (1) | EA004684B1 (de) |
EG (1) | EG24073A (de) |
ES (1) | ES2206403T3 (de) |
HK (1) | HK1051856A1 (de) |
HR (1) | HRP20020701B1 (de) |
HU (1) | HU229704B1 (de) |
IL (2) | IL150480A0 (de) |
MX (1) | MXPA02008242A (de) |
MY (1) | MY124784A (de) |
NO (1) | NO323422B1 (de) |
NZ (1) | NZ519796A (de) |
PE (1) | PE20011082A1 (de) |
PL (1) | PL208061B1 (de) |
PT (1) | PT1259513E (de) |
SI (1) | SI1259513T1 (de) |
SK (1) | SK287375B6 (de) |
SV (1) | SV2002000321A (de) |
TW (1) | TWI237024B (de) |
UA (1) | UA72791C2 (de) |
WO (1) | WO2001062760A2 (de) |
ZA (1) | ZA200205265B (de) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100364993C (zh) * | 2003-05-30 | 2008-01-30 | 江苏恒瑞医药股份有限公司 | 培美曲噻盐及其制备方法 |
CN100364994C (zh) * | 2004-11-25 | 2008-01-30 | 重庆医药工业研究院有限责任公司 | 培美曲塞二钠的一种新晶型及其制备方法 |
WO2007056135A1 (en) * | 2005-11-04 | 2007-05-18 | Merck & Co., Inc. | Method of treating cancers with saha and pemetrexed |
CN101300015A (zh) * | 2005-11-04 | 2008-11-05 | 默克公司 | 使用n-辛二酰苯胺异羟肟酸和厄洛替尼治疗癌症的方法 |
JP2008543973A (ja) * | 2006-08-14 | 2008-12-04 | シコール インコーポレイティド | ペメトレキセドの中間体の調製方法 |
ES2356792T3 (es) * | 2006-08-14 | 2011-04-13 | Sicor, Inc. | Procedimientos para la preparación de sales farmacéuticamente aceptables liofilizadas de pemetrexed diácido. |
EP1934226A2 (de) | 2006-08-14 | 2008-06-25 | Sicor, Inc. | Pemetrexed-diacid von hoher reinheit und verfahren zu dessen herstellung |
ATE490257T1 (de) * | 2006-08-14 | 2010-12-15 | Sicor Inc | Kristalline formen von pemetrexed-disäure und herstellungsverfahren dafür |
CA2667348A1 (en) * | 2006-11-03 | 2008-05-15 | University Of Maryland, Baltimore | Methods of using saha and bortezomib for treating multiple myeloma |
CA2681829A1 (en) | 2007-04-03 | 2008-10-16 | Dr. Reddy's Laboratories Ltd. | Solid forms of pemetrexed |
CN101417998B (zh) | 2007-10-24 | 2012-10-24 | 重庆医药工业研究院有限责任公司 | 一种培美曲塞盐的纯化方法 |
EP2072518A1 (de) * | 2007-12-23 | 2009-06-24 | Sun Pharma Advanced Research Company Limited | Stabile amorphe Form aus Pemextred Disodium |
EP2334685A4 (de) * | 2008-09-08 | 2011-10-26 | Reddys Lab Ltd Dr | Amorphes pemetrexed-dinatrium |
WO2010030598A2 (en) * | 2008-09-11 | 2010-03-18 | Dr. Reddy's Laboratories Limited | Pharmaceutical formulations comprising pemetrexed |
CN101684121B (zh) * | 2008-09-22 | 2013-04-03 | 重庆医药工业研究院有限责任公司 | 培美曲塞二酸的新晶型及其制备方法 |
CN102050825B (zh) * | 2009-11-05 | 2014-12-17 | 上海创诺制药有限公司 | 制备培美曲塞二钠2.5水结晶的方法 |
EP2504341A1 (de) | 2009-11-24 | 2012-10-03 | Azad Pharmaceutical Ingredients AG | Neue kristalline form von pemetrexed-dinatrium |
CN102372719B (zh) * | 2010-08-26 | 2013-10-30 | 齐鲁制药有限公司 | 培美曲塞二甲酯对甲苯磺酸盐晶型及其制备方法 |
KR101069128B1 (ko) * | 2011-03-10 | 2011-09-30 | 건일제약 주식회사 | 페메트렉시드 또는 그의 염을 포함하는 항산화제-비함유 주사용 용액 형태의 약학적 제제의 제조방법 |
US9051322B2 (en) | 2011-03-23 | 2015-06-09 | Scinopharm Taiwan, Ltd. | Process for the production of a pemetrexed salt |
JP5826371B2 (ja) * | 2011-03-25 | 2015-12-02 | サイノファーム タイワン リミテッド | ペメトレキセド塩の製造方法 |
ITRM20120398A1 (it) | 2012-08-08 | 2014-02-09 | Berlin Chemie Ag | Procedimento di sintesi pemetrexed e suo sale di lisina. |
CN102911176B (zh) * | 2012-10-10 | 2015-07-22 | 德州德药制药有限公司 | 一种培美曲塞二钠的制备方法 |
WO2014060959A1 (en) * | 2012-10-17 | 2014-04-24 | Shilpa Medicare Limited | Crystalline pemetrexed dipotassium process |
US20150359898A1 (en) | 2013-02-06 | 2015-12-17 | Cipla Limited | Pemetrexed Complexes and Pharmaceutical Compositions Containing Pemetrexed Complexes |
US20160051679A1 (en) | 2013-04-12 | 2016-02-25 | Actavis Group Ptc Ehf. | Pemetrexed Formulation |
KR101485243B1 (ko) * | 2013-05-08 | 2015-01-21 | 씨제이헬스케어 주식회사 | 안정화된 페메트렉시드 제제 |
JP6094388B2 (ja) * | 2013-06-07 | 2017-03-15 | ニプロ株式会社 | ペメトレキセドを含む注射用組成物 |
ES2657944T3 (es) | 2013-06-14 | 2018-03-07 | Synthon B.V. | Sal estable de arginina de pemetrexed y composiciones que la comprenden |
JP2016527227A (ja) | 2013-07-16 | 2016-09-08 | ドクター レディズ ラボラトリーズ リミテッド | ペメトレキセドトロメタミン塩の新規な結晶形 |
WO2015050230A1 (ja) | 2013-10-03 | 2015-04-09 | 富士フイルム株式会社 | 注射液製剤及びその製造方法 |
NZ630292A (en) * | 2013-11-25 | 2015-02-27 | Shilpa Medicare Ltd | Process for crystalline pemetrexed dipotassium salt |
NZ630299A (en) | 2014-06-30 | 2014-11-28 | Shilpa Medicare Ltd | Pemetrexed dipotassium formulations |
EP3212193A4 (de) * | 2014-10-30 | 2018-08-01 | ScinoPharm Taiwan, Ltd. | Kristalline formen von pemetrexed-disäure und herstellungsverfahren dafür |
CN105566328B (zh) * | 2014-11-06 | 2018-04-24 | 博瑞生物医药(苏州)股份有限公司 | 培美曲塞二酸多晶型的制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO169490C (no) * | 1988-03-24 | 1992-07-01 | Takeda Chemical Industries Ltd | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater |
KR0162654B1 (ko) * | 1989-12-11 | 1998-11-16 | 알렌 제이. 시니스갤리 | N-(피롤로[2,3-d]피리미딘-3-일아크릴)-글루타민산 유도체 |
US5416211A (en) * | 1992-09-25 | 1995-05-16 | Eli Lilly And Company | Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines |
JP2000516961A (ja) * | 1996-08-30 | 2000-12-19 | イーライ・リリー・アンド・カンパニー | 非古典的ピロロ[2,3―d]ピリミジン抗葉酸物質 |
ZA987550B (en) * | 1997-09-26 | 2000-02-21 | Lilly Co Eli | Processes and intermediates useful to make antifolates. |
TR200001220T2 (tr) * | 1997-09-26 | 2001-05-21 | Eli Lilly And Company | Antifolatlar yapmak için yararlı işlemler ve aramaddeler. |
AU6890800A (en) * | 1999-08-23 | 2001-03-19 | Eli Lilly And Company | A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-D]- pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor |
-
2001
- 2001-02-12 KR KR1020027011122A patent/KR100744917B1/ko not_active IP Right Cessation
- 2001-02-12 IL IL15048001A patent/IL150480A0/xx active IP Right Grant
- 2001-02-12 NZ NZ519796A patent/NZ519796A/xx not_active IP Right Cessation
- 2001-02-12 CZ CZ20022875A patent/CZ303772B6/cs not_active IP Right Cessation
- 2001-02-12 AT AT01906554T patent/ATE249462T1/de active
- 2001-02-12 JP JP2001562542A patent/JP4846158B2/ja not_active Expired - Fee Related
- 2001-02-12 DZ DZ013283A patent/DZ3283A1/fr active
- 2001-02-12 CN CNB01805627XA patent/CN1183135C/zh not_active Expired - Fee Related
- 2001-02-12 EP EP01906554A patent/EP1259513B1/de not_active Expired - Lifetime
- 2001-02-12 DE DE60100750T patent/DE60100750T2/de not_active Expired - Lifetime
- 2001-02-12 SK SK1186-2002A patent/SK287375B6/sk not_active IP Right Cessation
- 2001-02-12 SI SI200130032T patent/SI1259513T1/xx unknown
- 2001-02-12 PT PT01906554T patent/PT1259513E/pt unknown
- 2001-02-12 MX MXPA02008242A patent/MXPA02008242A/es active IP Right Grant
- 2001-02-12 ES ES01906554T patent/ES2206403T3/es not_active Expired - Lifetime
- 2001-02-12 EA EA200200905A patent/EA004684B1/ru not_active IP Right Cessation
- 2001-02-12 HU HU0204232A patent/HU229704B1/hu unknown
- 2001-02-12 US US10/182,991 patent/US7138521B2/en not_active Expired - Lifetime
- 2001-02-12 PL PL356423A patent/PL208061B1/pl unknown
- 2001-02-12 WO PCT/US2001/001229 patent/WO2001062760A2/en active IP Right Grant
- 2001-02-12 AU AU34451/01A patent/AU777047B2/en not_active Ceased
- 2001-02-12 BR BR0108604-9A patent/BR0108604A/pt not_active Application Discontinuation
- 2001-02-12 CA CA002400155A patent/CA2400155C/en not_active Expired - Fee Related
- 2001-02-12 DK DK01906554T patent/DK1259513T3/da active
- 2001-02-21 EG EG20010167A patent/EG24073A/xx active
- 2001-02-23 MY MYPI20010823A patent/MY124784A/en unknown
- 2001-02-23 CO CO01014634A patent/CO5261585A1/es not_active Application Discontinuation
- 2001-02-23 SV SV2001000321A patent/SV2002000321A/es unknown
- 2001-02-23 PE PE2001000194A patent/PE20011082A1/es not_active Application Discontinuation
- 2001-02-23 AR ARP010100844A patent/AR029471A1/es unknown
- 2001-02-23 TW TW090104119A patent/TWI237024B/zh not_active IP Right Cessation
- 2001-12-02 UA UA2002086886A patent/UA72791C2/uk unknown
-
2002
- 2002-06-27 IL IL150480A patent/IL150480A/en not_active IP Right Cessation
- 2002-07-01 ZA ZA200205265A patent/ZA200205265B/xx unknown
- 2002-08-21 NO NO20023974A patent/NO323422B1/no not_active IP Right Cessation
- 2002-08-26 HR HR20020701A patent/HRP20020701B1/xx not_active IP Right Cessation
-
2003
- 2003-04-09 HK HK03102573A patent/HK1051856A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60100750D1 (de) | NEUE KRISTALLINE FORM VON N-[4-[2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO[2,3-d]-PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMINSÄURE UND VERFAHREN FÜR IHRE HERSTELLUNG | |
CA2379560A1 (en) | Purine derivatives inhibitors of tyrosine protein kinase syk | |
DE60119283D1 (de) | Verfahren zur herstellung von 3-hydroxypicolinsäure-derivaten | |
WO2001014379A3 (en) | A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor | |
EE200200665A (et) | Triasolo (4,5-d)pürimidiiniühendi uus kristalne ja amorfne vorm, meetod selle valmistamiseks ning kasutamine | |
DE60040905D1 (de) | VERFAHREN ZUR HERSTELLUNG VON (E)-(6-i2-i4-(4-FLUORPHENYL)-6-ISOPROPYL-2-iMETHYL(METHYLSULFONYL)AMINO PYRIMIDIN-5-YL VINYL (4R,6S)-2,2-DIMETHYLi1,3 DIOXAN-4-YL)ESSIGSÄURE-TERT-BUTYLESTER | |
DE60116272D1 (de) | Malonsäure derivate, verfahren zu ihrer herstellung, ihre verwendung als inhibitor der faktor xa aktivität und pharmazeutische zusammensetzungen diese enthaltend | |
WO2003014080A3 (en) | Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues | |
DE50305374D1 (de) | Neue prodrugs von 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carbonsäure-(n -2-pyridil-n-2-hydroxycarbonylethyl)-amid, ihre herstellung und ihre verwendung als arzneimittel | |
DE60122704D1 (de) | Herstellung von iminodiessigsäure-derivaten aus monoethanolamin-substraten | |
HUP0402253A3 (en) | Process for the purification of n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)-phenyl]-n-ethylacetamide(zaleplon) and the preparation of its novel crystalline forms and pharmaceutical compositions containing the latters | |
BR1100847A (pt) | Derivados de 2- [4 - (4-azolilbutil) -1- piperazinil] -pirimidina, compostos, processo de preparação dos compostos, utilização dos compostos, e, composições farmacêuticas | |
DE60120990D1 (de) | Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen | |
DE60222806D1 (de) | Verfahren zur herstellung von (1,4,5)-oxadiazepinderivaten | |
EE200000619A (et) | Oktahüdro-6,10-diokso-6H-püridasino[1,2-a][1,2]diasepiin-1-karboksüülhappe derivaadid, nende ratseemiline segu, valmistamismeetod ja kasutamine ning vaheühendid | |
ATE179424T1 (de) | N-heteroaryl substituierte propanamid-derivate brauchbar zur behandlung cardiovascularer krankheiten | |
DE60125915D1 (de) | Verfahren zur herstellung von quinolin-derivaten und ihre zwischenstufen | |
DE60204014D1 (de) | Chlormethylierung von thiophene | |
EE200200410A (et) | Meetod atsetüülamidiniofenüülalanüültsükloheksüülglütsüülpüridinioalaniinamiidide valmistamiseks ning selleks vajalikud lähte- ja vaheühendid | |
DE60208365D1 (de) | Verwendung von pyridoindolonderivaten zur herstellung von antikrebsmitteln | |
DE60304703D1 (de) | Neue 3-(4-oxo-4h-chromen-2-yl)-(1h)-quinolin-4-one-derivate; verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten | |
DE50206070D1 (de) | Verfahren zur Herstellung von copolymeren hydrophob modifizierten Polyglutaminsäurederivaten und ihre Verwendung | |
DE60117846D1 (de) | Herstellung von 6-aminocaprinsäurealkylestern | |
DE60115538D1 (de) | Verfahren zur Herstellung von hochreinen 5,5'-bi-1H-Tetrazoldiammoniumsalzen | |
WO2002022582A3 (en) | Solid salt forms of n-[2-[4-[2-(1-methylethoxy)phenyl]-1-piperazinyl]ethyl]-2-oxo-1-piperidineacetamide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336 |
|
8328 | Change in the person/name/address of the agent |
Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN |